SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from ZIX CORP (CIK 0000855612) — Jan 31, 2005

ZIX CORP (CIK 0000855612)
Date: Jan. 31, 2005 · CIK: 0000855612 · Accession: 0000950134-05-001707

AI Filing Summary & Sentiment

File numbers found in text: 333-120548

Date
January 31, 2005
Author
Assistant Director
Form
CORRESP
Company
ZIX CORP (CIK 0000855612)

Letter

Via Edgar and Hand — Delivery Securities and Exchange Commission Zix Corporation Registration Statement on Form S-3, as amended Pre-Effective Amendment No. 2, Filed January 31, 2005 File No. 333-120548

Dear Ms. Jacobs:

This letter responds to the Commission’s letter of January 23, 2005. The changes described herein are incorporated in the marked, enclosed Pre-Effective Amendment No. 2, which is being filed with the Commission via EDGAR on January 31, 2005.

Commission Comment

1. Please disclose in greater detail the “other specified conditions” that would give ZixCorp the right to force conversion of the convertible notes.

Company Response

The prospectus has been amended to add a description of the other specified conditions. Also, since the other specified conditions refer to the “events of default” and “repurchase events,” the discussion of these has also been expanded. See “Principal Payments under the Convertible Notes” and “Events of Default and Repurchase Rights” on pages 1-4 of the prospectus.

Commission Comment

2. Please provide a more detailed discussion of the restrictive covenants imposed by the $10,000,000 convertible note.

Company Response

The prospectus has been amended to add a description of significant restrictive covenants. See “Restrictive Covenants” on page 4 of the prospectus.

Commission Comment

3. Please consider including risk factor disclosure concerning the dilutive effects of your convertible note and warrants.

Company Response

Additional language has been added to the risk factor “Further issuances of equity securities may be dilutive to current shareholders” to address the convertible note and warrants. See the page 13 of the prospectus.

Conclusion

We hope that the foregoing addresses the Commission’s comments. Please call Ronald Woessner (214-370-2219) or Tanya Foreman (214-370-2223) for any questions you may have about the foregoing.

Very truly yours,
/s/ Ronald A. Woessner

Show Raw Text
CORRESP
1
filename1.htm

corresp

[Zix Corporation Letterhead]

January 31, 2005

Via Edgar and Hand — Delivery

Barbara C. Jacobs

Assistant Director

Mail Stop 4-6

Securities and Exchange Commission

450 Fifth Street, N.W.

Washington, D.C., 20549-0406

    Re:

    Zix Corporation

Registration Statement on Form S-3, as amended

Pre-Effective Amendment No. 2, Filed January 31, 2005

File No. 333-120548

Dear Ms. Jacobs:

     This letter responds to the Commission’s letter of January 23, 2005. The changes described
herein are incorporated in the marked, enclosed Pre-Effective Amendment No. 2, which is being filed with the Commission via
EDGAR on January 31, 2005.

     Commission Comment

    1.
    Please disclose in greater detail the “other specified conditions” that would
give ZixCorp the right to force conversion of the convertible notes.

     Company Response

     The prospectus has been amended to add a description of the other specified conditions. Also,
since the other specified conditions refer to the “events of default” and “repurchase events,” the
discussion of these has also been expanded. See “Principal Payments under the Convertible Notes”
and “Events of Default and Repurchase Rights” on pages 1-4 of the prospectus.

     Commission Comment

    2.
    Please provide a more detailed discussion of the restrictive covenants imposed
by the $10,000,000 convertible note.

     Company Response

     The prospectus has been amended to add a description of significant restrictive covenants.
See “Restrictive Covenants” on page 4 of the prospectus.

     Commission Comment

    3.
    Please consider including risk factor disclosure concerning the dilutive
effects of your convertible note and warrants.

     Company Response

     Additional language has been added to the risk factor “Further issuances of equity securities
may be dilutive to current shareholders” to address the convertible note and warrants. See the
page 13 of the prospectus.

     Conclusion

     We hope that the foregoing addresses the Commission’s comments. Please call Ronald Woessner
(214-370-2219) or Tanya Foreman (214-370-2223) for any questions you may have about the foregoing.

Very truly yours,

/s/ Ronald A. Woessner

Ronald A. Woessner

Senior Vice President & General Counsel